@GbadegesinLab
Account based inUnited States!
About this account
- Account based in
- United States
- Connected via
- United States App Store
X says this location may be affected by a proxy or VPN.
Account-level information from X, not a live location or the device used for a specific post.
Peds kidney Doc, Physician Scientist, Assoc Dean PSD @DukeMedSchool. Leveraging kidney genomics to discover effective & safe therapy for nephrotic syndrome.
Joined December 2021
- Tweets525
- Following965
- Followers1.2K
- Likes3.2K
Pinned Tweet
Final version of our paper SSNS candidate gene CLVS1 regulates podocyte oxidative stress— is out insight.jci.org/articles/vie…, @JCI_insight. Findings ID potential alt/steroid sparing therapy for NS
Gbadegesin Lab retweeted
New from Dr Varner, Dr Lane and Dr Gbadegesin in Advances in Kidney Disease and Health
Genetic Nephrotic Syndrome in Children and Adolescents: An Update
pubmed.ncbi.nlm.nih.gov/4233…
ALT Detailed diagram of a podocyte showing cellular components like mitochondria, endoplasmic reticulum, nucleus, and actin cytoskeleton with labeled proteins and complexes.
Gbadegesin Lab retweeted
Looking forward to tomorrow’s Penn/CHOP Kidney Innovation Center Symposium and Annual Research Day:
“Kidney Genetics and Health Disparities: APOL1, Global Ancestry, and Disease Risk”
📍 Smilow Rubenstein Auditorium, Philadelphia, PA
🗓 Monday, May 11, 2026
An exciting day bringing together leaders in nephrology, genetics, computational biology, and precision medicine to discuss how human genetics and multi-omics are reshaping our understanding of kidney disease and health disparities.
#KidneyResearch #Nephrology #APOL1 #PrecisionMedicine #HealthEquity #PennMedicine #CHOP @PennKidney
Gbadegesin Lab retweeted
🚨 Our new paper just dropped !!! Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes nature.com/articles/s41591-0…
Gbadegesin Lab retweeted
We’re thrilled to share a breakthrough moment in advancing treatment for #RareKidneyDisease. Our therapy for #FSGS has received FDA approval, the first and only approved medicine for FSGS. #InRareForLife Press release: bit.ly/47V4jFJ
Excited to share the link for our new paper in KI. Big step towards predicting response to rx @ initial presentation of Peds nephrotic syndrome @ASPNeph @ISGDtweets @nephcure Huge global collab efforts nam11.safelinks.protection.o…
Impt piece of work on precise diagnosis of APOL1 AMKD. Pts with N264K (M1) co-inherited with G2 may have other kid dxs & not AMKD. Huge implications for use of emerging AMKD therapy and interpretation of CT. Congratulations #Simone Sanna-Cherchi and team🎉 jamanetwork.com/journals/jam…
Enjoy this review focusing on the applicability of KDIGO 2025 guidelines on mx of Peds NS in the US. Highlight, levamisole not approved for use in Humans in the US!! Thanks @goKDIGO for a nice piece. My pleasure working with ChiaShi Wang on this🙏🏽
KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children by Chia-shi Wang and Rasheed Gbadegesin
bit.ly/4q9yAqo (FREE)
Gbadegesin Lab retweeted
We welcomed 25 new members of the Robert J. #LefkowitzSociety at the #Duke #OPSD Physician- Scientist Fall Symposium. The event featured a keynote from Nobel Laurate Dr. Robert Lefkowitz & presentations from Drs. Jenny O’Brien and Michael Forrester. Thanks to everyone who joined!
Gbadegesin Lab retweeted
🎉 Celebrate Duke’s physician-scientist community at OPSD Fall Mini-Symposium on Nov 11, 4–6 PM (MSRBIII Rm 1125)! Featuring Nobel Laureate Dr. Lefkowitz @robertjlefkowi1, research talks & awardee recognition.🥙All Duke trainees/faculty welcome! Read more: mailchi.mp/duke/opsd-sept25-…
Huge congratulations to Duke Pump Class of 2025👍
Congrats to the Duke R25 Summer Undergraduate PUMP students on their oral presentations today. #NephForward
Gbadegesin Lab retweeted
A few more days to register to the first ever, recurrent FSGS conference !!
If you are not blown away by the program, come for the food :)
#rFSGS #FSGS #raredisease @ASNKidney @ASPNeph @ISGDtweets @nephcure
🚨 We are officially two weeks out from the #rFSGSConference! 🚨
Reserve your spot so you can join us in Washington, DC to discuss #rFSGS research, funding, and treatments. Register today: scgcorp.com/rFSGS2024/Regist…
Our group is migrating to Bluesky platform. We have already posted a number of cool and new discoveries @gbadegesinlab.bsky.social Please follow our latest updates🙏🏽
Looking forward to having major stakeholders in the room to discuss clinical and research areas of need in rFSGS. Hopefully we can move the needle closer to effective and durable treatments @ASPNeph @ISGDtweets @nephcure 🙏🏽
The #rFSGS Meeting in DC, December 9th is close and keeps gaining traction!
We upsized the room venue, there is still time for you to come !!!
There is still time to register! Don't miss it! scgcorp.com/rFSGS2024/Regist……
#FSGS #rFSGS #RareDisease #genetics #NephTwitter
@rFSGSInitiative
@GlomCon
@CUIMCGlomCenter
@ColumbiaMed
@jradnephro
@ASNKidney
@ASPNeph
@RareDiseases
@ISNkidneycare
@IPNA_PedNeph
@thePNRC
@ISGDtweets
@nephcure
@NephroticF
@treatNephrotic
@the_asci
@MiamiAlessia
@GbadegesinLab
@OpeyemiOlabisi8
@AstridWeins
@SumitMohanMD
@TheSampsonLab
@kidneyomicsamps
@Moinsaleem
@rheault_m
@priyagoose
@NIDDKgov
@KimReidy2
@EloiseSalmonMD
@LauraMarianiMD
@Martinelli_Elen
@NadaAlachkar
We are proud of all our Trainees and Early Career Physician Scientists at Duke. We appreciate the great mentor pool that we are blessed with at Duke and the outstanding OPSD staff, present and past. Solid leadership @MaryEKlotman @DukeMedSchool nitter.cf/dukeopsd/status/185717…
is-gd.org/en/news-from-isgd/…
Excellent easy to digest summary of our paper @NEJM
nejm.org/doi/10.1056/NEJMoa2… by Ms Alissa Kocer our outstanding Science Communication expert @DukeMedSchool @Duke_CTSI @DukeGenomics Thanks @ISGDtweets More work to be done ✅
A great resource for genetic evaluation pre kidney transplantation. Great team work, thanks for putting the team together Dr Christie Thomas @uiowa Nephrology🙏🏽
Excited to see this published from our @AST_KPCOP Genetics work group!!! Led by #ChristieThomas
Evaluation for genetic disease in kidney transplant candidates: A practice resource.
@KidneyPrince @TersMireille @GbadegesinLab @AST_info @amjtransplant
amjtransplant.org/article/S1…